NCT01012687View on ClinicalTrials.gov

Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Essential Hypertension
Interventions
DRUG

perindopril erbumine

8 mg tablet

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01012687 - Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions | Biotech Hunter | Biotech Hunter